Effect of antiarrhythmic therapy on mortality in survivors of myocardial infarction with asymptomatic complex ventricular arrhythmias: Basel Antiarrhythmic Study of Infarct Survival (BASIS)

Department of Internal Medicine, University Hospital, Basel, Switzerland.

In view of the high risk of sudden cardiac death and the prognostic importance of complex ventricular ectopic activity, the effects of prophylactic antiarrhythmic treatment were investigated prospectively in patients with persisting asymptomatic complex arrhythmias after myocardial infarction. End points were total mortality and arrhythmic events (sudden death, sustained ventricular tachycardia and ventricular fibrillation). Of 1,220 consecutively screened survivors of myocardial infarction, 312 had Lown class 3 or 4b arrhythmia on 24 h electrocardiographic recordings before hospital discharge and consented to the study. They were randomized to individualized antiarrhythmic treatment (Group 1, n = 100), treatment with low dose amiodarone, 200 mg/day (Group 2, n = 98) or no antiarrhythmic therapy (Group 3 [control group], n = 114). During the 1 year follow-up period, 10 patients in Group 1 died, as did 5 in Group 2 and 15 in Group 3. On the basis of an intention to treat analysis, the probability of survival of patients given amiodarone was significantly greater than that of control patients (p less than 0.05). In addition, arrhythmic events were significantly reduced by amiodarone (p less than 0.01). These effects were less marked and not significant for individually treated patients (Group 1). These findings suggest that low dose amiodarone decreases mortality in the 1st year after myocardial infarction in patients at high risk of sudden death.

This article has been cited by other articles:

				J. P. Piccini, J. S. Berger, and C. M. O'Connor Amiodarone for the prevention of sudden cardiac death: a meta-analysis of randomized controlled trials Eur. Heart J., May 2, 2009; 30(10): 1245 - 1253. [Abstract] [Full Text] [PDF]

				A. Breitenstein, S.F. Stampfli, G.G. Camici, A. Akhmedov, H.R. Ha, F. Follath, A. Bogdanova, T.F. Luscher, and F.C. Tanner Amiodarone Inhibits Arterial Thrombus Formation and Tissue Factor Translation Arterioscler Thromb Vasc Biol, December 1, 2008; 28(12): 2231 - 2238. [Abstract] [Full Text] [PDF]

				P. Vassallo and R. G. Trohman Prescribing Amiodarone: An Evidence-Based Review of Clinical Indications JAMA, September 19, 2007; 298(11): 1312 - 1322. [Abstract] [Full Text] [PDF]

				J. W. Schrickel, J. O. Schwab, A. Yang, H. Bielik, A. Bitzen, B. Luderitz, and T. Lewalter Pro-arrhythmic effects of amiodarone and concomitant rate-control medication Europace, June 1, 2006; 8(6): 403 - 407. [Abstract] [Full Text] [PDF]

				A Y Patwala and D J Wright Device based treatment of heart failure Postgrad. Med. J., May 1, 2005; 81(955): 286 - 291. [Abstract] [Full Text] [PDF]

				T. C. McCarthy, P. T. Pollak, E. A. Hanniman, and C. J. Sinal Disruption of Hepatic Lipid Homeostasis in Mice after Amiodarone Treatment Is Associated with Peroxisome Proliferator-Activated Receptor-{alpha}Target Gene Activation J. Pharmacol. Exp. Ther., December 1, 2004; 311(3): 864 - 873. [Abstract] [Full Text] [PDF]

				D. G Katritsis and A.J. Camm Nonsustained ventricular tachycardia: where do we stand? Eur. Heart J., July 1, 2004; 25(13): 1093 - 1099. [Abstract] [Full Text] [PDF]

				M. P. Anstadt and J. E. Lowe Cardiopulmonary Resuscitation Card. Surg. Adult, January 1, 2003; 2(2003): 471 - 494. [Full Text]

				G Nichol, F McAlister, B Pham, A Laupacis, B Shea, M Green, A Tang, and G Wells Meta-analysis of randomised controlled trials of the effectiveness of antiarrhythmic agents at promoting sinus rhythm in patients with atrial fibrillation Heart, June 1, 2002; 87(6): 535 - 543. [Abstract] [Full Text] [PDF]

				P. Della Bella, R. De Ponti, J.A.S. Uriarte, C. Tondo, C. Klersy, C. Carbucicchio, C. Storti, S. Riva, and M. Longobardi Catheter ablation and antiarrhythmic drugs for haemodynamically tolerated post-infarction ventricular tachycardia. Long-term outcome in relation to acute electrophysiological findings Eur. Heart J., March 1, 2002; 23(5): 414 - 424. [Abstract] [Full Text] [PDF]

				F. Di Maio, V. Rizzo, S. V. Campbell, F. Petretto, A. Corbellini, A. Bianchi, G. Bianco, F. Meloni, V. Bernardo, and D. Tallarico Effects of Cardiac Rehabilitation on Atrial Wave in Patients After Myocardial Infarction Angiology, December 1, 2001; 52(12): 827 - 833. [Abstract] [PDF]

				G. D. Sanders, M. A. Hlatky, N. R. Every, K. M. McDonald, P. A. Heidenreich, L. S. Parsons, and D. K. Owens Potential Cost-Effectiveness of Prophylactic Use of the Implantable Cardioverter Defibrillator or Amiodarone after Myocardial Infarction Ann Intern Med, November 20, 2001; 135(10): 870 - 883. [Abstract] [Full Text] [PDF]

				S.G. Priori, E. Aliot, C. Blomstrom-Lundqvist, L. Bossaert, G. Breithardt, P. Brugada, A.J. Camm, R. Cappato, S.M. Cobbe, C. Di Mario, et al. Task Force on Sudden Cardiac Death of the European Society of Cardiology Eur. Heart J., August 2, 2001; 22(16): 1374 - 1450. [PDF]

				M.M. Scheinman Amiodarone after acute myocardial infarcation Eur. Heart J., February 1, 2000; 21(3): 177 - 178. [PDF]

				M.V Elizari, J.M Martinez, C Belziti, M Ciruzzi, R Perez De La Hoz, A Sinisi, J Carbajales, O Scapin, J Garguichevich, L Girotti, et al. Morbidity and mortality following early administration of amiodarone in acute myocardial infarction Eur. Heart J., February 1, 2000; 21(3): 198 - 205. [Abstract] [PDF]

				S. J. Connolly Evidence-Based Analysis of Amiodarone Efficacy and Safety Circulation, November 9, 1999; 100(19): 2025 - 2034. [Full Text] [PDF]

				R. J. Noble and M. E. Tavel Management of Acute Myocardial Infarction With Hypotension Chest, November 1, 1999; 116(5): 1464 - 1467. [Full Text] [PDF]

				P. J. Welch, R. L. Page, and M. H. Hamdan Management of ventricular arrhythmias: A trial-based approach J. Am. Coll. Cardiol., September 1, 1999; 34(3): 621 - 630. [Abstract] [Full Text] [PDF]

				M. H. Crawford, S. J. Bernstein, P. C. Deedwania, J. P. DiMarco, K. J. Ferrick, A. Garson Jr, L. A. Green, H. L. Greene, M. J. Silka, P. H. Stone, et al. ACC/AHA guidelines for ambulatory electrocardiography: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the Guidelines for Ambulatory Electrocardiography) developed in collaboration with the North American Society for Pacing and Electrophysiology J. Am. Coll. Cardiol., September 1, 1999; 34(3): 912 - 948. [Full Text] [PDF]

				M. K. Chung, R. A. Schweikert, B. L. Wilkoff, M. J. Niebauer, S. L. Pinski, R. G. Trohman, G. A. Kidwell, F. J. Jaeger, V. A. Morant, D. P. Miller, et al. Is hospital admission for initiation of antiarrhythmic therapy with sotalol for atrial arrhythmias required?: yield of in-hospital monitoring and prediction of risk for significant arrhythmia complications J. Am. Coll. Cardiol., July 1, 1998; 32(1): 169 - 176. [Abstract] [Full Text] [PDF]

				I. Sim, K. M. McDonald, P. W. Lavori, C. M. Norbutas, and M. A. Hlatky Quantitative Overview of Randomized Trials of Amiodarone to Prevent Sudden Cardiac Death Circulation, November 4, 1997; 96(9): 2823 - 2829. [Abstract] [Full Text]

				M. J. Domanski, D. P. Zipes, and E. Schron Treatment of Sudden Cardiac Death : Current Understandings From Randomized Trials and Future Research Directions Circulation, June 17, 1997; 95(12): 2694 - 2699. [Full Text]

				C. H. Hennekens, C. M. Albert, S. L. Godfried, J. M. Gaziano, and J. E. Buring Adjunctive Drug Therapy of Acute Myocardial Infarction -- Evidence from Clinical Trials N. Engl. J. Med., November 28, 1996; 335(22): 1660 - 1668. [Full Text] [PDF]

				D. Bocker, W. Haverkamp, M. Block, M. Borggrefe, D. Hammel, and G. Breithardt Comparison of d,l-Sotalol and Implantable Defibrillators for Treatment of Sustained Ventricular Tachycardia or Fibrillation in Patients With Coronary Artery Disease Circulation, July 15, 1996; 94(2): 151 - 157. [Abstract] [Full Text]

				M. J. Silver, J. Young, E. J. Topol, A. Colli, L. A. Sechi, S. De Carli, E. Bartoli, S. N. Singh, R. D. Fletcher, and S. G. Fisher Amiodarone in Congestive Heart Failure N. Engl. J. Med., December 14, 1995; 333(24): 1639 - 1641. [Full Text]

				G. Breithardt Amiodarone in Patients with Heart Failure N. Engl. J. Med., July 13, 1995; 333(2): 121 - 122. [Full Text]

				F. Avanzini, R. Latini, A. Maggioni, F. Colombo, E. Santoro, M. G. Franzosi, G. Tognoni, and GISSI Investigators Antiarrhythmic Drug Prescription in Patients After Myocardial Infarction in the Last Decade: Experience of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico (GISSI) Arch Intern Med, May 22, 1995; 155(10): 1041 - 1045. [Abstract] [PDF]

				D. P. Zipes Are Implantable Cardioverter-Defibrillators Better Than Conventional Antiarrhythmic Drugs for Survivors of Cardiac Arrest? Circulation, April 15, 1995; 91(8): 2115 - 2117. [Full Text]

				G. C. Larsen, M. R. Stupey, C. G. Walance, K. K. Griffith, J. E. Cutler, J. Kron, and J. H. McAnulty Recurrent Cardiac Events in Survivors of Ventricular Fibrillation or Tachycardia: Implications for Driving Restrictions JAMA, May 4, 1994; 271(17): 1335 - 1339. [Abstract] [PDF]

				D. G. Zarembski, P. E. Nolan Jr, M. K. Slack, and A. C. Caruso Empiric Long-term Amiodarone Prophylaxis Following Myocardial Infarction: A Meta-Analysis Arch Intern Med, December 13, 1993; 153(23): 2661 - 2667. [Abstract] [PDF]

				A. E. Epstein, A. P. Hallstrom, W. J. Rogers, P. R. Liebson, A. A. Seals, J. L. Anderson, J. D. Cohen, R. J. Capone, D. G. Wyse, and the CAST Investigators Mortality Following Ventricular Arrhythmia Suppression by Encainide, Flecainide, and Moricizine After Myocardial Infarction: The Original Design Concept of the Cardiac Arrhythmia Suppression Trial (CAST) JAMA, November 24, 1993; 270(20): 2451 - 2455. [Abstract] [PDF]

				K. K. Teo, S. Yusuf, and C. D. Furberg Effects of Prophylactic Antiarrhythmic Drug Therapy in Acute Myocardial Infarction: An Overview of Results From Randomized Controlled Trials JAMA, October 6, 1993; 270(13): 1589 - 1595. [Abstract] [PDF]

				J. W. Mason and The Electrophysiologic Study versus Electrocardiog A Comparison of Seven Antiarrhythmic Drugs in Patients with Ventricular Tachyarrhythmias N. Engl. J. Med., August 12, 1993; 329(7): 452 - 458. [Abstract] [Full Text]

				H. R. Middlekauff, I. Wiener, L. A. Saxon, and W. G. Stevenson Low-Dose Amiodarone for Atrial Fibrillation: Time for a Prospective Study? Ann Intern Med, June 15, 1992; 116(12_Part_1): 1017 - 1020. [Abstract] [PDF]

				R. J. Krone The Role of Risk Stratification in the Early Management of a Myocardial Infarction Ann Intern Med, February 1, 1992; 116(3): 223 - 237. [Abstract] [PDF]

				AMIODARONE MAY LOWER MORTALITY FROM ARRHYTHMIAS AFTER MI Journal Watch (General), January 11, 1991; 1991(111): 4 - 4. [Full Text]